Ventana Biotech, Inc. (VNTAD) Announces Name Change to Ventana Global, Inc. and Significant Outstanding Share Reduction

Rhea-AI Summary

Ventana Biotech (VNTAD) announced its name change to Ventana Global, Inc. along with a significant share restructuring through a 1-for-20 reverse stock split effective January 14, 2025. The company has reduced its authorized shares from 3 billion to 500 million, while outstanding shares decreased from approximately 1.08 billion to 53.78 million.

The ticker symbol will temporarily remain as VNTAD until mid-February 2025, when it will change to VNTA. According to CEO Stephen Replin, these changes reflect the company's expanded strategic vision and aim to create a more investor-friendly capital structure. The name change also addresses marketplace confusion about the company's biotech focus, as it plans to pursue broader global business opportunities.

Positive

• Significant reduction in share count potentially improving stock marketability
• Authorized shares reduced by 83.3% from 3B to 500M
• Outstanding shares reduced by 95% from 1.08B to 53.78M

Negative

• Reverse stock split might be perceived negatively by market
• Unclear new business direction after moving away from biotech focus

Posturing for future growth!

Denver, Colorado--(Newsfile Corp. - January 29, 2025) - Ventana Biotech, Inc. ("Ventana" or the "Company") today announced that it has changed its name to Ventana Global, Inc. (OTC Pink: VNTAD) from Ventana Biotech, Inc. Concurrently with the name change, the Company has significantly reduced its authorized and outstanding shares as the result of a 1 for 20 reverse stock split which was effective January 14, 2025.

The name change reflects the Company's evolving strategic focus and its intention to pursue a broader range of global business opportunities.

• Authorized Shares: The Company has reduced its authorized shares from 3,000,000,000 to 500,000,000.

• Outstanding Shares: Effective January 14, 2025, the Company has reduced its outstanding shares from 1,075,665,990 shares to approximately 53,783,299 (not reflective of fractional shares), as the result of the reverse stock split.

• Trading Symbol: VNTAD until mid-February when the ticker symbol becomes VNTA.

"Both the change of name, and outstanding share reduction initiatives mark significant steps forward for the development of Ventana Global, Inc," stated Stephen Replin, President and CEO of the Company.

He continued stating "Further, we believe that this new capital structure, and change of name, will enable us to pursue corporate opportunities that may have been unavailable to us as Ventana Biotech, Inc. more easily."

"These actions align our corporate identity with our expanded strategic vision and have been done to create a more robust and investor-friendly capital structure for our long-term growth. With an adjustment to the number of outstanding shares, we are well-positioned to pursue strategic growth opportunities and enhance shareholder value more easily."

The president also stated that "the marketplace confusion suggesting that the Company is involved in the biotech industry as the result of its former name will no longer be a factor to the perception of our business focus in the view of 3^rd parties. This additional simplification adds to our vision for the growth of the Company."

About Ventana Global, Inc.

Ventana Global, Inc. is currently in the business of servicing a portfolio of loans. Additionally, the Company has formed and is developing a consulting program that will provide services to third party businesses and individuals. The consulting subsidiary of LaunchPad Cafe, Ltd. (itself a wholly owned subsidiary of Ventana Global, Inc.) is named MPM Business Group, LTD.

The Company also has a division of LaunchPad Café, Ltd entitled LaunchPad Hot Sauces, LTD which has entered a drop shipping/affiliate arrangement with the manufacturer of a line of hot sauces. This drop-shipping arrangement does not require the Company to carry inventory or fulfill orders. LaunchPad Hot Sauces, LTD will be compensated by being paid a percentage of the gross sales volume attributable to the Company.

Neither division has generated revenues for Ventana since its formation as of this date.

Contact Information:
Ventana Global, Inc.
Stephen Replin, CEO
(303) 916-9676
sreplin@gmail.com

Cautionary Statement Concerning Forward-Looking Statements:

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements represent the Company's expectations or beliefs concerning future events and can generally be identified by the use of statements that include words such as "estimate," "project," "believe," "anticipate," "shooting to," "intend," "plan," "foresee," "likely," "will," "would," "appears," "goal," "target" or similar words or phrases. Forward-looking statements include, but are not limited to, statements regarding the Company's expectations for revenue growth and new customer and business opportunities. These forward-looking statements are subject to risks, uncertainties, and other factors, many of which are outside of the Company's control, that could cause actual results to differ materially from the results expressed or implied in the forward-looking statements, including, among others: the lack of capital to pursue expansion activities, and as the result, the Company's ability to compete against new and existing competitors is limited; its ability to identify and move forward with acquisition targets; and the Company's ability to attract and retain qualified personnel to direct this anticipated growth. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or the future performance of the Company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. The Company expressly disclaims any intent or obligation to update any of the forward-looking statements made in this release or in any of its filings except as may be otherwise stated by the Company.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/238817

FAQ

What is the new share count for VNTAD after the 1-for-20 reverse split in January 2025?

After the 1-for-20 reverse stock split effective January 14, 2025, VNTAD's outstanding shares were reduced from 1,075,665,990 to approximately 53,783,299 shares.

When will VNTAD's ticker symbol change to VNTA?

The ticker symbol will change from VNTAD to VNTA in mid-February 2025.

How many authorized shares does Ventana Global have after the January 2025 reduction?

Ventana Global reduced its authorized shares from 3,000,000,000 to 500,000,000.

Why did Ventana Biotech change its name to Ventana Global in 2025?

The company changed its name to reflect its evolving strategic focus and intention to pursue a broader range of global business opportunities, moving away from the biotech-specific focus.